This page contains regularly updated information on Realm Therapeutics securities and the Company's most significant shareholders. Realm Therapeutics is traded on Nasdaq. There are no restrictions on the trading of Realm Therapeutics' shares
As of 27 February 2019
Number of securities in issue: 116,561,917 10p Ords
There are no shares held in treasury.
Percentage of Securities not in public hands: 35.62%
As of 27 February 2019, the following shareholders held interests in excess of 3% of ordinary share capital.
|BVF Partners LP||15,322,266||13.15%|
|BAVARIA Industries Group AG||6,944,948||5.96%|
|Abingworth BioEquities Master Fund Ltd.||6,384,277||5.48%|
|Sussex Trading Company Limited||6,148,880||5.28%|
|Oracle Management Limited||5,410,196||4.64%|
|Kanton Services Limited||4,629,196||3.97%|
|Polar Capital Funds Plc||3,500,000||3.00%|
* Executive Director